Partner Headlines - CLSN

  1. Mid-Afternoon Market Update: Crude Oil Down 5%; SunCoke Energy ...

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. Celsion Corporation Enrolls First Patient in the OVATION Study

    Benzinga
  4. Morning Market Gainers

    Benzinga
  5. Benzinga's Top Initiations

    Benzinga
  6. Morning Market Gainers

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Morning Market Losers

    Benzinga
  9. Celsion Announces Potent, Durable Preclinical Lung Expression ...

    Benzinga
  10. Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase ...

    Benzinga
  11. Earnings Scheduled For May 11, 2015

    Benzinga
  12. Morning Market Gainers

    Benzinga
  13. UPDATE: Celsion Slightly Falls Back Following Treatment News

    Benzinga
  14. Celsion Jumps On Interim Data On Cancer Drug

    Benzinga
  15. Morning Market Gainers

    Benzinga
  16. Benzinga's Top Initiations

    Benzinga
  17. Celsion Presents Preclinical Data For Its TheraSilence Platform ...

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  20. Celsion to Present Updated Overall Survival Results from HEAT ...

    Benzinga
  21. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly ...

    Benzinga
  22. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  23. Celsion Announces $15M At-The-Market Registered Direct Offering ...

    Benzinga
  24. Morning Market Movers

    Benzinga
  25. Celsion Presents Combined Clinical Data from Two Phase I Trials ...

    Benzinga
  26. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan ...

    Benzinga
  27. Stocks Hitting 52-Week Lows

    Benzinga
  28. Celsion Halted Wednesday, Says Will Host Conference Call Jan ...

    Benzinga
  29. Option Speculators Circle Celsion

    SchaeffersResearch
  30. Stocks Hitting 52-Week Highs

    Benzinga
  31. UPDATE: Dawson James Initiates Celsion at Market Outperform on ...

    Benzinga
  32. Celsion Corp Says Continuing Phase 2 Study

    Benzinga
  33. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 ...

    GuruFocus
  34. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga
  35. Health Care Sector Wrap

    FoxBusiness
  36. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness
  37. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch
  38. Celsion Announces Collaboration With the University of Oxford ...

    Benzinga
  39. Celsion Announces Resubmission With Philips Healthcare of Combined ...

    Benzinga
  40. Celsion Announces ThermoDox Commercial Supply Agreement With ...

    Benzinga
  41. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga
  42. Celsion Completes Consultative Review Process With EMA for Phase ...

    Benzinga
  43. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  44. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus
Trading Center